Omeros Corporation logo
Omeros Corporation OMER
$ 11.12 2.02%

Annual report 2025
added 03-31-2026

report update icon

Omeros Corporation Long Term Debt Current 2011-2026 | OMER

Annual Long Term Debt Current Omeros Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.8 M 5.24 M 4.59 M - - 2.74 M 2.28 M 889 K 490 K 198 K 73 K 6.45 M 5.6 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.45 M 73 K 3.12 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.12 -0.36 % $ 441 M usaUSA
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
4.21 M $ 8.32 3.67 % $ 228 M israelIsrael
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 23.65 0.08 % $ 3.01 B usaUSA
BioVie BioVie
BIVI
74.5 K $ 1.46 2.82 % $ 2.16 M usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
522 K $ 2.32 4.98 % $ 908 M israelIsrael
BioNTech SE BioNTech SE
BNTX
45 M $ 91.44 0.29 % $ 27.2 B germanyGermany
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
BioXcel Therapeutics BioXcel Therapeutics
BTAI
65 K $ 1.16 -2.12 % $ 14.2 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.1 4.56 % $ 311 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.17 1.44 % $ 6.9 B israelIsrael
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
636 K $ 19.48 0.39 % $ 1.74 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Codexis Codexis
CDXS
2.94 M $ 1.95 6.87 % $ 170 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Cerus Corporation Cerus Corporation
CERS
2.9 M $ 1.91 2.69 % $ 364 M usaUSA
Cullinan Management Cullinan Management
CGEM
780 K $ 15.11 4.71 % $ 910 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
1.83 M $ 1.72 -0.87 % $ 201 M usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
440 K $ 0.46 -13.02 % $ 5.27 M israelIsrael
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
437 K $ 24.95 1.05 % $ 3.05 B usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.55 M $ 31.33 0.85 % $ 2.08 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
1.63 M $ 10.27 0.98 % $ 137 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
730 K $ 1.6 1.27 % $ 107 M usaUSA